These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12517245)

  • 1. Frovatriptan: a review.
    Goldstein J
    Expert Opin Pharmacother; 2003 Jan; 4(1):83-93. PubMed ID: 12517245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M; Ravasio R
    Clin Drug Investig; 2009; 29(11):693-702. PubMed ID: 19813772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M
    CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frovatriptan review.
    Markus F; Mikko K
    Expert Opin Pharmacother; 2007 Dec; 8(17):3029-33. PubMed ID: 18001261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
    Balbisi EA
    Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R; Géraud G; Goldstein J; Cady R; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frovatriptan: pharmacological differences and clinical results.
    Rapoport AM
    Curr Med Res Opin; 2001; 17 Suppl 1():s68-70. PubMed ID: 12463282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A; Ryan R; Goldstein J; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
    Elkind AH; MacGregor EA
    Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G; Spierings EL; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic evaluation of frovatriptan.
    Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD; Elkind AH; Schreiber C; Keywood C
    Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frovatriptan: a review of drug-drug interactions.
    Buchan P; Wade A; Ward C; Oliver SD; Stewart AJ; Freestone S
    Headache; 2002 Apr; 42 Suppl 2():S63-73. PubMed ID: 12028322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frovatriptan.
    Easthope SE; Goa KL
    CNS Drugs; 2001; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headache.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2002 Sep; 38(9):615-29. PubMed ID: 12582449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.
    Allais G; Benedetto C
    Drug Des Devel Ther; 2016; 10():3225-3236. PubMed ID: 27757013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of frovatriptan.
    Buchan P; Keywood C; Wade A; Ward C
    Headache; 2002 Apr; 42 Suppl 2():S54-62. PubMed ID: 12028321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J; Keywood C;
    Headache; 2002 Jan; 42(1):41-8. PubMed ID: 12005274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine.
    Balbisi EA
    Ther Clin Risk Manag; 2006 Sep; 2(3):303-8. PubMed ID: 18360605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.